- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 417/10
Total number of patents in this class: 1203
10-year publication summary
|
77
|
93
|
101
|
85
|
80
|
55
|
80
|
66
|
56
|
41
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5728 |
53 |
| Merck Sharp & Dohme LLC | 3734 |
34 |
| Bristol-myers Squibb Company | 4742 |
29 |
| LG Chem, Ltd. | 17921 |
29 |
| F. Hoffmann-La Roche AG | 7837 |
23 |
| Genentech, Inc. | 4104 |
21 |
| Boehringer Ingelheim International GmbH | 4493 |
18 |
| Syngenta Participations AG | 1524 |
18 |
| Amgen Inc. | 4427 |
16 |
| Omeros Corporation | 305 |
15 |
| Novartis AG | 10262 |
14 |
| Gilead Sciences, Inc. | 2222 |
14 |
| Bayer AG | 3501 |
13 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
11 |
| Janssen Pharmaceutica N.V. | 3168 |
10 |
| Bayer Pharma AG | 1014 |
10 |
| Astex Therapeutics Limited | 207 |
10 |
| Hodogaya Chemical Co., Ltd. | 431 |
10 |
| Glaxosmithkline LLC | 528 |
9 |
| Samsung Display Co., Ltd. | 38627 |
9 |
| Other owners | 837 |